Sally Pipes: “Democrats Can’t End Private-Sector Drug Innovation Fast Enough”

Expanding Medicare’s price controls into the private market would make the business of drug discovery all but impossible in the U.S.—and mark the end of America’s reign as the world’s leading source of life-saving medicines.